Stem cell patent news (12/7/10)

[Sciclips]

Recent stem patents/patent applications highlights:

1. Stem cell-derived cancer cells for the immuno treatment of cancer
2. Stem cell differentiation and moblization by bioelectrical
stimulation
3. ECAT11 expression or ECAT11 promoter activity as a marker for
selecting clones of iPScells
4. Stem cell based siRNA delivery through gap junctions
5. Stem cell targeting antibodies for the treatment of muscle
diseases
6. An apparatus and methods for stem cell based treatment for spinal
cord injury
7. SIRT1 inhibitor for increasing replicative lifespan of stem cells
9. Nicotine receptor agonists in stem cell mobilization
10. Melphalan-cyclodextrin combination for conditioning pediatric
stem cell transplantation patients
11. Triiodothyronine (T3) thyroid hormone for the enrichment of
insulin- expressing stem cells
12. Induced pluripotent stem (iPS) cells by modulating the expression
reprogramming factor
13. Treatment of eye diseases using encapsulated stem cells encoding
and secreting neuroprotective or anti-angiogenic factor

Details: http://tinyurl.com/yjzcvpo